Halozyme Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 13.15 M | $885.25 M | 2.28% | 11.18% |
| VANGUARD GROUP INC | 01/29/2026 | 11.57 M | $778.45 M | -0.54% | 9.83% |
| STATE STREET CORP | 02/13/2026 | 5.12 M | $344.69 M | 2.04% | 4.35% |
| INVESCO LTD. | 02/19/2026 | 3.65 M | $245.51 M | 12.39% | 3.10% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 3.22 M | $216.87 M | -2.07% | 2.75% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.73 M | $183.99 M | 38.34% | 2.32% |
| MORGAN STANLEY | 02/13/2026 | 2.66 M | $178.90 M | 52.99% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.43 M | $163.78 M | 0.08% | 2.07% |
| SNYDER CAPITAL MANAGEMENT L P | 02/12/2026 | 2.40 M | $161.47 M | -12.24% | 2.05% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.10 M | $141.61 M | 1.24% | 1.80% |
| NORGES BANK | 02/10/2026 | 1.90 M | $128.20 M | 100.00% | 1.63% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 02/09/2026 | 1.84 M | $124.03 M | 100.00% | 1.57% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.84 M | $123.53 M | -3.77% | 1.56% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.65 M | $111.01 M | -37.76% | 1.41% |
| FEDERATED HERMES, INC. | 02/12/2026 | 1.57 M | $105.97 M | 8.54% | 1.34% |
| JUPITER ASSET MANAGEMENT LTD | 02/10/2026 | 1.57 M | $105.63 M | 96.05% | 1.34% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 1.52 M | $102.19 M | 100.00% | 1.29% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.46 M | $98.52 M | 19.25% | 1.24% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.41 M | $94.59 M | 139.99% | 1.19% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 02/18/2026 | 1.38 M | $92.85 M | 0.61% | 1.18% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 02/13/2026 | 1.37 M | $92.29 M | 19.94% | 1.17% |
| UBS GROUP AG | 01/29/2026 | 1.37 M | $91.91 M | -53.64% | 1.16% |
| CONGRESS ASSET MANAGEMENT CO /MA | 01/09/2026 | 1.30 M | $87.64 M | -9.35% | 1.11% |
| LSV ASSET MANAGEMENT | 02/06/2026 | 1.30 M | $87.56 M | 2.77% | 1.11% |
| MIZUHO MARKETS AMERICAS LLC | 02/06/2026 | 1.27 M | $85.38 M | 270.80% | 1.08% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.25 M | $84.44 M | -0.56% | 1.07% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.24 M | $83.58 M | -1.55% | 1.06% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 02/05/2026 | 1.22 M | $82.35 M | -0.12% | 1.04% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 02/17/2026 | 1.22 M | $82.38 M | 57.60% | 1.04% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.21 M | $81.41 M | 12.39% | 1.03% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.16 M | $77.96 M | 19.60% | 0.99% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.10 M | $73.78 M | -6.07% | 0.94% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 1.10 M | $70.83 M | 1.37% | 0.93% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 1.01 M | $68.09 M | 30.32% | 0.86% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 961.13 K | $64.68 M | -8.73% | 0.82% |
| PACER ADVISORS, INC. | 02/24/2026 | 937.29 K | $63.08 M | 95.73% | 0.80% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 931.70 K | $62.70 M | -10.00% | 0.79% |
| SEI INVESTMENTS CO | 02/13/2026 | 901.14 K | $60.65 M | 95.48% | 0.77% |
| CAPITAL WORLD INVESTORS | 02/11/2026 | 879.87 K | $59.22 M | 5.80% | 0.75% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 876.96 K | $59.02 M | -2.36% | 0.75% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 863.96 K | $58.14 M | -9.82% | 0.74% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 784.27 K | $52.78 M | 88.70% | 0.67% |
| BOSTON TRUST WALDEN CORP | 01/28/2026 | 781.84 K | $52.62 M | -6.24% | 0.67% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 754.51 K | $50.78 M | -28.68% | 0.64% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 733.56 K | $49.37 M | 124.35% | 0.63% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 717.37 K | $48.28 M | -45.49% | 0.61% |
| NUVEEN, LLC | 02/12/2026 | 699.89 K | $47.10 M | 7.16% | 0.59% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 633.53 K | $42.64 M | -18.46% | 0.54% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 626.22 K | $42.14 M | -32.29% | 0.53% |
| ROYAL BANK OF CANADA | 02/17/2026 | 617.41 K | $41.55 M | -35.07% | 0.52% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Halozyme Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 891 institutional investors and hedge funds held shares of Halozyme Therapeutics Inc.. The most heavily invested institutionals were:
Boston Partners: 2.68 M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC: 2.53 M
DIMENSIONAL FUND ADVISORS LP: 2.08 M
ROYAL LONDON ASSET MANAGEMENT LTD: 1.61 M
WELLS FARGO & COMPANY/MN: 1.54 M
LSV ASSET MANAGEMENT: 1.37 M
105.06% of Halozyme Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 183.70 M shares in the last 24 months. This purchase volume represents approximately $12.52 B in transactions.